227 related articles for article (PubMed ID: 27488686)
1. Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.
Deng J; Chen W; Deng H
J Fluoresc; 2016 Nov; 26(6):1987-1996. PubMed ID: 27488686
[TBL] [Abstract][Full Text] [Related]
2. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
Deng J; Gou Y; Chen W; Fu X; Deng H
Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
4. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
5. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
[TBL] [Abstract][Full Text] [Related]
6. Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.
Megger DA; Rosowski K; Radunsky C; Kösters J; Sitek B; Müller J
Dalton Trans; 2017 Apr; 46(14):4759-4767. PubMed ID: 28338141
[TBL] [Abstract][Full Text] [Related]
7. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the copper(II) complexes cytotoxicity to cancer cells through bound to human serum albumin.
Gou Y; Zhang Y; Qi J; Zhou Z; Yang F; Liang H
J Inorg Biochem; 2015 Mar; 144():47-55. PubMed ID: 25573806
[TBL] [Abstract][Full Text] [Related]
9. Complexes of cytotoxic chelators from the dipyridyl ketone isonicotinoyl hydrazone (HPKIH) analogues.
Bernhardt PV; Mattsson J; Richardson DR
Inorg Chem; 2006 Jan; 45(2):752-60. PubMed ID: 16411711
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
Rodić MV; Leovac VM; Jovanović LS; Spasojević V; Joksović MD; Stanojković T; Matić IZ; Vojinović-Ješić LS; Marković V
Eur J Med Chem; 2016 Jun; 115():75-81. PubMed ID: 27084495
[TBL] [Abstract][Full Text] [Related]
11. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
12. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
13. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
14. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.
Nagababu P; Barui AK; Thulasiram B; Devi CS; Satyanarayana S; Patra CR; Sreedhar B
J Med Chem; 2015 Jul; 58(13):5226-41. PubMed ID: 26068145
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes.
Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H
J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.
Raja DS; Bhuvanesh NS; Natarajan K
J Biol Inorg Chem; 2012 Feb; 17(2):223-37. PubMed ID: 21932155
[TBL] [Abstract][Full Text] [Related]
20. Pd(II) complexes with N-heteroaromatic hydrazone ligands: Anticancer activity, in silico and experimental target identification.
Bjelogrlić SK; Todorović TR; Kojić M; Senćanski M; Nikolić M; Višnjevac A; Araškov J; Miljković M; Muller CD; Filipović NR
J Inorg Biochem; 2019 Oct; 199():110758. PubMed ID: 31299379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
